P450-mediated dehydrotyrosine formation during WS9326 biosynthesis proceeds via dehydrogenation of a specific acylated dipeptide substrate

Cytochrome-P450peptide antibiotics
Written By Dana Matthews

Songya Zhang, Lin Zhang, Anja Greule, Julien Tailhades, Edward Marschall, Panward Prasongpholchai, Daniel J. Leng, Jingfan Zhang, Jing Zhu, Joe A. Kaczmarski, Ralf B. Schittenhelm, Oliver Einsle, Colin J. Jackson, Fabrizio Alberti, Andreas Bechthold, Youming Zhang, Manuela Tosin*, Tong Si*, and Max J. Cryle*

P450-mediated dehydrotyrosine formation during WS9326 biosynthesis proceeds via dehydrogenation of a specific acylated dipeptide substrate

Acta Pharmaceutica Sinica B, 2023

Dana Matthews
Previous

Structural Insights into a Side Chain Cross-Linking Biarylitide P450 from RiPP Biosynthesis
Next

Complex Inhibitory Mechanism of Glycomimetics with Heparanase